Cargando…
DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes
BACKGROUND: Recent studies have shown the beneficial effect of dipeptidyl peptidase-4 (DPP4) inhibitor on bone turnover in diabetes mellitus. However, little clinical evidence for DPP4 activity in newly diagnosed type 2 diabetes is available. This study was designed to investigate the relationship b...
Autores principales: | Qiu, Min, Zhai, Shuheng, Liu, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719533/ https://www.ncbi.nlm.nih.gov/pubmed/33312197 http://dx.doi.org/10.1155/2020/8874272 |
Ejemplares similares
-
10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea
por: Baek, Yeon-Hee, et al.
Publicado: (2021) -
Osteoporosis, osteopenia, and atherosclerotic vascular disease
por: Aronow, Wilbert S.
Publicado: (2011) -
Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics
por: Montejo, A. L., et al.
Publicado: (2023) -
Comparative assessment of fracture risk among osteoporosis and osteopenia patients: a cross-sectional study
por: Tomasevic-Todorovic, Snezana, et al.
Publicado: (2018) -
The risk of osteopenia/osteoporosis and psoriatic disease: A systematic review
por: Schauer, Anna, et al.
Publicado: (2022)